Pawel Blecharz
Krakow Branch
Krakow, MA, Poland
Krakow, MA, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Emerging immune checkpoint inhibitor strategies in cervical cancer: a scoping review of ongoing clinical trials.
Journal: Expert review of anticancer therapy
Published: May 19, 2026
Interpreting p53 IHC-TP53 NGS discordance in endometrial cancer: a mechanism-based diagnostic framework and clinical implications.
Journal: Frontiers in oncology
Published: April 22, 2026
Immune-Related Adverse Events of Cemiplimab Therapy in Advanced Cervical Cancer-Data from the Polish-Czech Cervical Cancer Immunotherapy Group (PCCIG-01) with a Review of the Literature.
Journal: Antibodies (Basel, Switzerland)
Published: March 26, 2026
Sentinel lymph node distribution in endometrial cancer: clinical patterns and implications from a 292-patient cohort.
Journal: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
Published: December 08, 2025
Integrating locoregional therapy with ongoing immunotherapy after oligoprogression in recurrent/metastatic cervical cancer.
Journal: European journal of obstetrics, gynecology, and reproductive biology
Published: June 09, 2025
Real-world efficacy and safety of nivolumab and ipilimumab in metastatic renal cell carcinoma: a Polish multicenter study.
Journal: Future oncology (London, England)
Published: May 20, 2025
False detection and the value of combined tracer mapping in endometrial cancer: a dual case presentation.
Journal: Journal of surgical case reports
Published: April 30, 2025
Updated Guidelines for the Diagnosis and Treatment of Endometrial Carcinoma: The Polish Society of Gynecological Oncology (2025v).
Journal: Current oncology (Toronto, Ont.)
Published: April 14, 2025
Phase II clinical trial of nirogacestat in patients with relapsed ovarian granulosa cell tumours.
Journal: Clinical and translational medicine
Published: April 04, 2025
Thyroid disorders as predictors of cemiplimab efficacy in recurrent/metastatic cervical cancer: real-world evidence from Poland.
Journal: Frontiers in immunology
Published: April 02, 2025
Last Updated: 09/26/2026